Therapeutic drug monitoring in the treatment of HIV-infection
- 28 February 2003
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 27 (2) , 117-128
- https://doi.org/10.1016/s1386-6532(03)00033-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- PharmAdaptAIDS, 2002
- Therapeutic drug monitoring in HIV infection: current status and future directionsAIDS, 2002
- Pros and cons of therapeutic drug monitoring of antiretroviral agentsCurrent Opinion in Infectious Diseases, 2002
- Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patientsAIDS, 2001
- The role of therapeutic drug monitoring in treatment of HIV infectionBritish Journal of Clinical Pharmacology, 2001
- A Retrospective, Cohort-Based Survey of Patients Using Twice-Daily Indinavir + Ritonavir Combinations: Pharmacokinetics, Safety, and EfficacyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor TherapyThe Journal of Infectious Diseases, 2000
- Drug Susceptibility in HIV Infection After Viral Rebound in Patients Receiving Indinavir-Containing RegimensJAMA, 2000
- Indinavir Concentrations and Antiviral EffectPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Therapeutic Drug Monitoring—the Need for Audit?Scottish Medical Journal, 1985